Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1124261C details a Lewis acid-catalyzed route for polyene esters, offering significant cost reduction and supply chain reliability for high-purity carotenoid intermediate manufacturing.
Novel patent CN109081861A offers high-purity 16a-hydroxy prednisonlone via solid base catalysis. Reduces cost and impurities for reliable pharmaceutical intermediate supply chains.
Novel patent CN104774196A outlines high-purity benzimidazole derivative synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN108642119B details a lipase-catalyzed method for high-purity chiral intermediates, offering cost-effective and scalable manufacturing solutions.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Patent CN109609582B reveals a novel microbial deracemization route for L-glufosinate-ammonium, offering superior purity and cost-effective supply chain solutions.
Patent CN113860981A reveals a mild NaDT-catalyzed route for trifluoromethyl thioesters. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN104447548B details a scalable route for HCV intermediates. This method offers high purity and cost efficiency for global supply chains.
Patent CN107022587A details a novel enzymatic route for Ezetimibe intermediates using tubular reactors. Discover cost reduction in API manufacturing and high-purity supply solutions.
Patent CN112194585A reveals a high-yield reductive amination route for Bromhexine Hydrochloride, eliminating corrosive thionyl chloride and enhancing supply chain stability.
Patent CN104610357A reveals ionic liquid method for high-purity zoledronic acid sodium. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.
Patent CN115803318A details an enantioselective route for high-purity tetrahydroquinoline intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN100339346C details oxidative dimerization for high-purity tetraalkylbisphenol. Reduces waste and enhances supply chain reliability for industrial buyers.
Advanced one-step caprolactam synthesis using phosphate buffer and ionic liquids. Delivers high selectivity, reduced corrosion, and streamlined manufacturing for nylon precursors.
Novel patent CN119080622A enables metal-free isoquinolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103508865A reveals solid alkali catalysis for high-purity aldehyde synthesis. Reduces wastewater and enhances supply chain reliability for global buyers.
This report analyzes patent CN114835577B for aldehyde synthesis. It offers cost reduction in pharmaceutical intermediates manufacturing and ensures supply chain reliability for global buyers.
Patent CN111732589A reveals a novel batch-feeding strategy for entecavir intermediates, achieving >99% purity and significantly reducing reaction times for scalable manufacturing.
Patent CN102285972A details a green microwave-assisted route for Tegafur, eliminating toxic chloroform and reducing energy consumption for cost-effective manufacturing.
Patent CN117003758A details enzymatic route for Sitagliptin. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.